OtoBand for Tinnitus
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you do not take benzodiazepines (a type of medication often used for anxiety or sleep) and that your tinnitus is not caused by any medication you are currently taking.
Is OtoBand safe for treating tinnitus?
How does the OtoBand treatment for tinnitus differ from other treatments?
The OtoBand treatment for tinnitus is unique because it likely involves a novel approach, potentially similar to electrical stimulation methods like the Audimax Theraband, which use inaudible, transdermal (through the skin) electrical stimulation to target tinnitus symptoms. This method differs from traditional treatments like oral medications or sound therapy, offering a non-invasive alternative that directly stimulates the auditory system.678910
What is the purpose of this trial?
This trial tests if the OtoBand, a wearable device, can reduce the loudness of tinnitus. It targets people with tinnitus and compares the effects of a real device to a non-active version. Participants will report any changes in their tinnitus loudness.
Research Team
Didier Depireux, PhD
Principal Investigator
Otolith Labs
Eligibility Criteria
This trial is for people aged 18-70 with tinnitus lasting at least 90 days and a significant impact on their life, as measured by a specific questionnaire. Participants need internet access, an online payment account, and no recent skull surgery or implants. Those taking certain medications like benzodiazepines or with recent eye issues are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the OtoBand and placebo device to assess tinnitus loudness reduction
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- OtoBand
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Otolith Labs
Lead Sponsor